Instil Bio, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Instil Bio, Inc. (TIL) reported Increase (Decrease) in Other Noncurrent Liabilities of -$8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-13
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2024-12-31 was $77.00K.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-09-30 was $1.87M.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-06-30 was -$1.67M.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$79.00K, a 202.60% decline from fiscal 2024.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $77.00K.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$12.00K, a 100.74% decline from fiscal 2022.
- Instil Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $1.63M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | -$79.00K 10-K · filed 2026-03-27 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $77.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.87M derived: sum of 2 quarters · filed 2025-03-04 | $195.00K derived: sum of 3 quarters · filed 2025-03-04 | -$12.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $195.00K derived: sum of 2 quarters · filed 2024-11-13 | -$12.00K 10-Q · filed 2024-11-13 | $1.62M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.88M 10-Q · filed 2023-08-14 | -$251.00K derived: sum of 3 quarters · filed 2024-03-21 | -$251.00K derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | -$207.00K 10-Q · filed 2023-05-11 | $1.42M derived: sum of 2 quarters · filed 2024-03-21 | $1.42M derived: sum of 3 quarters · filed 2024-03-21 | $1.42M derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.63M derived: sum of 2 quarters · filed 2024-03-21 | $1.63M derived: sum of 3 quarters · filed 2024-03-21 | $1.63M 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |